Thrombolytic Therapy in Acute Myocardial Infarction: Part II-rt-PA
- 1 March 1989
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 73 (2) , 387-407
- https://doi.org/10.1016/s0025-7125(16)30679-4
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Update from the thrombolysis in myocardial infarction trialJournal of the American College of Cardiology, 1987
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.Circulation, 1987
- Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarctionJournal of the American College of Cardiology, 1987
- Percutaneous transluminal coronary angioplasty after thrombolytic therapy: A prospective controlled randomized trialJournal of the American College of Cardiology, 1986
- Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.Circulation, 1986
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen ActivatorScience, 1983
- Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1979
- Fibrinolysis in the Animal OrganismNature, 1947